Real-World Evidence On COVID 19 Vaccines Coming Into US FDA
Executive Summary
Peter Marks says agency is getting first RWE readouts of vaccine safety; AstraZeneca’s vaccine has no expiration date, so stockpile is not currently at risk of being thrown out, the CBER director tells a House hearing.
You may also be interested in...
AZ Vaccine Safety Review To Give Rapid Answer- But No Guarantee Of EU Consensus
Member states do not have to follow European Medicines Agency guidance – which means division and confusion could persist after it issues its verdict on the safety of the AstraZeneca vaccine.
US Is Holding On To Its Supply Of AstraZeneca COVID-19 Vaccine
US is keeping a ‘small inventory’ of AstraZeneca’s vaccine so people in the US can receive it immediately following authorization, White House official says. President Biden seeks to boost vaccine manufacturing in India in parntership with India, Japan, and Australia.
Patent Process Reforms Proposed By US PTO Could Be ‘Quite Burdensome’ For Applicants
Patent office requests comments on its proposed initiatives, with continuation patents appearing a particular target. PTO asks if filing a terminal disclaimer for patents that are a variation of each other should be an admission they are obvious.